Adverum Biotechnologies
ADVM
ADVM
77 hedge funds and large institutions have $49.8M invested in Adverum Biotechnologies in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $101K
Holders
77
Holding in Top 10
1
Calls
–
Puts
$101K
Top Buyers
| 1 | +$1.44M | |
| 2 | +$862K | |
| 3 | +$756K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$593K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$493K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$1.34M | |
| 3 | -$690K | |
| 4 |
CCM
Cadian Capital Management
New York
|
-$589K |
| 5 |
Goldman Sachs
New York
|
-$458K |